Paying user area
Try for free
Eli Lilly & Co. pages available for free this week:
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Income Statement
- Common-Size Balance Sheet: Assets
- Analysis of Profitability Ratios
- Analysis of Solvency Ratios
- Dividend Discount Model (DDM)
- Net Profit Margin since 2005
- Return on Equity (ROE) since 2005
- Price to Earnings (P/E) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Eli Lilly & Co. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Statement
| 12 months ended: | Revenue | Net income (loss) |
|---|---|---|
| Dec 31, 2025 | ||
| Dec 31, 2024 | ||
| Dec 31, 2023 | ||
| Dec 31, 2022 | ||
| Dec 31, 2021 | ||
| Dec 31, 2020 | ||
| Dec 31, 2019 | ||
| Dec 31, 2018 | ||
| Dec 31, 2017 | ||
| Dec 31, 2016 | ||
| Dec 31, 2015 | ||
| Dec 31, 2014 | ||
| Dec 31, 2013 | ||
| Dec 31, 2012 | ||
| Dec 31, 2011 | ||
| Dec 31, 2010 | ||
| Dec 31, 2009 | ||
| Dec 31, 2008 | ||
| Dec 31, 2007 | ||
| Dec 31, 2006 | ||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Over the period examined, revenue demonstrates a generally increasing trend, albeit with some volatility. Initial growth from 2005 to 2008 is followed by a dip in 2009, then a period of relatively stable revenue through 2012. A more substantial increase begins in 2013, accelerating significantly from 2020 onwards, culminating in substantial gains in 2023 and 2024. Net income exhibits a more erratic pattern. While positive for much of the period, it experiences a significant loss in 2008 and a smaller loss in 2017. Overall, net income shows a strong upward trend in the latter part of the period, mirroring the revenue growth.
- Revenue Trend
- Revenue increased from US$14,645 million in 2005 to US$65,179 million in 2025. The compound annual growth rate (CAGR) from 2005 to 2025 is approximately 14.8%. The period between 2005 and 2008 shows consistent growth, followed by a slight decline in 2012. The most significant revenue expansion occurs between 2020 and 2025, indicating a potential shift in market dynamics or product portfolio.
- Net Income Volatility
- Net income fluctuated considerably. A loss of US$2,072 million was recorded in 2008, followed by a recovery and positive net income in subsequent years. Another loss of US$204 million occurred in 2017. However, net income demonstrates a strong positive trend from 2019, reaching US$20,640 million in 2025. This suggests improved profitability or cost management in recent years, potentially linked to the revenue increases.
- Relationship between Revenue and Net Income
- While generally correlated, the relationship between revenue and net income is not always direct. For example, revenue continued to grow in 2008 despite a substantial net loss. This could be attributed to increased costs or other factors impacting profitability. The strong correlation observed from 2020 onwards suggests improved operational efficiency and a greater ability to translate revenue growth into net income.
The observed trends suggest a company that has navigated periods of both growth and challenge. The recent substantial increases in both revenue and net income indicate a period of strong performance, potentially driven by successful product launches, market expansion, or improved operational efficiencies. The earlier volatility in net income highlights the importance of monitoring cost structures and external factors that can impact profitability.
Balance Sheet: Assets
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2025 | ||
| Dec 31, 2024 | ||
| Dec 31, 2023 | ||
| Dec 31, 2022 | ||
| Dec 31, 2021 | ||
| Dec 31, 2020 | ||
| Dec 31, 2019 | ||
| Dec 31, 2018 | ||
| Dec 31, 2017 | ||
| Dec 31, 2016 | ||
| Dec 31, 2015 | ||
| Dec 31, 2014 | ||
| Dec 31, 2013 | ||
| Dec 31, 2012 | ||
| Dec 31, 2011 | ||
| Dec 31, 2010 | ||
| Dec 31, 2009 | ||
| Dec 31, 2008 | ||
| Dec 31, 2007 | ||
| Dec 31, 2006 | ||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Over the period examined, both current assets and total assets exhibited considerable fluctuation. Initial observation reveals a period of decline followed by growth, and then a significant surge in recent years.
- Current Assets Trend
- Current assets decreased from approximately $10.8 billion in 2005 to a low of $9.7 billion in 2006. A subsequent increase was observed, peaking at $12.5 billion in 2007 and remaining relatively stable through 2010. From 2010 to 2017, current assets demonstrated a consistent upward trend, reaching $19.2 billion. A notable decrease occurred in 2018, falling to $13.7 billion, before recovering to $18.5 billion in 2021. The most substantial growth occurred between 2021 and 2025, with current assets increasing from $18.0 billion to $55.6 billion.
- Total Assets Trend
- Total assets mirrored the trend observed in current assets, declining from $24.6 billion in 2005 to $22.0 billion in 2006. Growth followed, peaking at $29.2 billion in 2008, then experiencing a slight dip in 2009. A period of moderate growth continued through 2014, reaching $37.2 billion. A decrease was noted in 2015, followed by a recovery and further growth to $44.9 billion in 2017. A slight decrease occurred in 2018, before a period of expansion. The most dramatic increase in total assets occurred between 2021 and 2025, rising from $49.5 billion to $112.5 billion.
- Relationship between Current and Total Assets
- Throughout the period, current assets consistently represented a significant portion of total assets, generally ranging between 40% and 50%. However, the proportion increased substantially in the later years, reaching approximately 46% in 2024 and 48% in 2025. This suggests a growing reliance on short-term assets relative to the overall asset base.
- Growth Acceleration
- The period from 2021 to 2025 demonstrates an accelerated rate of growth in both current and total assets compared to the preceding years. This suggests a significant shift in the company’s asset structure and potentially reflects substantial investments, acquisitions, or increased operational activity. The magnitude of the increase in 2024 and 2025 is particularly noteworthy.
In summary, the asset base experienced a period of volatility followed by substantial growth, particularly in the most recent years of the examined period. The increasing proportion of current assets within the total asset base warrants further investigation.
Balance Sheet: Liabilities and Stockholders’ Equity
Eli Lilly & Co., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
| Current liabilities | Total liabilities | Total debt | Total Eli Lilly and Company shareholders’ equity | |
|---|---|---|---|---|
| Dec 31, 2025 | ||||
| Dec 31, 2024 | ||||
| Dec 31, 2023 | ||||
| Dec 31, 2022 | ||||
| Dec 31, 2021 | ||||
| Dec 31, 2020 | ||||
| Dec 31, 2019 | ||||
| Dec 31, 2018 | ||||
| Dec 31, 2017 | ||||
| Dec 31, 2016 | ||||
| Dec 31, 2015 | ||||
| Dec 31, 2014 | ||||
| Dec 31, 2013 | ||||
| Dec 31, 2012 | ||||
| Dec 31, 2011 | ||||
| Dec 31, 2010 | ||||
| Dec 31, 2009 | ||||
| Dec 31, 2008 | ||||
| Dec 31, 2007 | ||||
| Dec 31, 2006 | ||||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
An examination of the balance sheet information reveals significant shifts in the company’s liabilities and stockholders’ equity between 2005 and 2025. Overall, both total liabilities and total debt demonstrate a general upward trajectory, particularly in the latter half of the observed period, while stockholders’ equity exhibits more volatility.
- Current Liabilities
- Current liabilities fluctuated considerably. After a decrease from 2005 to 2006, they remained relatively stable until 2008, when a substantial increase was recorded. Following this, current liabilities decreased before rising again, peaking in 2023 and 2024. This suggests potential changes in short-term financing strategies or working capital management.
- Total Liabilities
- Total liabilities generally increased over the period, with notable jumps in 2008 and again beginning in 2020. The increase from 2022 to 2023 was particularly pronounced, more than doubling from US$53.143 billion to US$64.443 billion, and continuing to US$85.941 billion in 2025. This indicates a growing reliance on debt financing or an accumulation of other obligations. A period of decline was observed between 2013 and 2014.
- Total Debt
- Total debt mirrored the trend of total liabilities, with increases observed in 2008, and more significantly from 2020 onwards. The largest increase in total debt occurred between 2023 and 2025, rising from US$25.225 billion to US$42.503 billion. This suggests an increased appetite for borrowing or a need to refinance existing debt. Prior to 2008, debt levels were considerably lower.
- Stockholders’ Equity
- Stockholders’ equity experienced significant fluctuations. It increased from 2005 to 2013, then declined sharply in 2014 and 2015, reaching a low in 2017. A dramatic decrease occurred in 2019, falling to US$2.607 billion, before beginning a recovery. By 2025, stockholders’ equity had increased substantially to US$26.535 billion, though it remains lower than levels seen in the earlier part of the period. This volatility could be attributed to factors such as share repurchases, dividend payments, or changes in retained earnings.
The substantial increases in liabilities and debt, coupled with the fluctuations in stockholders’ equity, suggest a changing capital structure. The company appears to be increasingly reliant on debt financing, particularly in recent years. The recovery in stockholders’ equity in the later years of the period is a positive sign, but the overall trend indicates a shift towards a more leveraged financial position.
Cash Flow Statement
| 12 months ended: | Net cash provided by operating activities | Net cash (used for) provided by investing activities | Net cash provided by (used for) financing activities |
|---|---|---|---|
| Dec 31, 2025 | |||
| Dec 31, 2024 | |||
| Dec 31, 2023 | |||
| Dec 31, 2022 | |||
| Dec 31, 2021 | |||
| Dec 31, 2020 | |||
| Dec 31, 2019 | |||
| Dec 31, 2018 | |||
| Dec 31, 2017 | |||
| Dec 31, 2016 | |||
| Dec 31, 2015 | |||
| Dec 31, 2014 | |||
| Dec 31, 2013 | |||
| Dec 31, 2012 | |||
| Dec 31, 2011 | |||
| Dec 31, 2010 | |||
| Dec 31, 2009 | |||
| Dec 31, 2008 | |||
| Dec 31, 2007 | |||
| Dec 31, 2006 | |||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Over the period examined, the company’s cash flow statement reveals significant fluctuations across all three activities: operating, investing, and financing. A general observation is an increasing volatility in cash flows, particularly in the later years of the period.
- Operating Activities
- Net cash provided by operating activities demonstrated a substantial increase from 2005 to 2008, peaking at approximately US$7.3 billion. Following this peak, a decline was observed through 2015, reaching a low of US$2.8 billion. From 2016 onwards, operating cash flow generally trended upwards, with a significant surge in 2023 and 2024, reaching US$8.8 billion and US$16.8 billion respectively. This recent increase suggests improved operational efficiency or increased profitability. The year 2023 represents a substantial deviation from prior years.
- Investing Activities
- Net cash flow from investing activities exhibited considerable variability. The period between 2005 and 2010 showed predominantly negative cash flow, indicating consistent investment. 2006 showed a positive inflow, but this was followed by substantial outflows in 2007 and 2008. The years 2011 through 2015 continued to show largely negative cash flows, though with some moderation. A positive cash flow was recorded in 2018, but this was followed by significant negative cash flows in 2019, 2020, 2021, 2022, 2023 and 2024, with the outflows increasing in magnitude each year. The consistent negative values suggest ongoing investment in assets, potentially including acquisitions or capital expenditures, with a marked acceleration in the scale of these investments in recent years.
- Financing Activities
- Net cash flow from financing activities was consistently negative for much of the period, indicating a reliance on external funding or a return of capital to investors. Significant negative cash flows were observed in 2006 and 2009. A positive cash flow was recorded in 2017, but this was short-lived, with subsequent years showing negative values. The year 2023 showed a positive cash flow, suggesting potential debt reduction or equity issuance. The overall trend suggests the company frequently utilizes financing to support its operations and investments, with a recent shift towards potentially strengthening the balance sheet.
The interplay between these three activities reveals a complex financial picture. The increasing operating cash flow in recent years, coupled with substantial and growing negative investing cash flow, suggests the company is generating significant cash from its core business but deploying it aggressively into investments. The financing activities appear to be used to manage the overall cash position, supplementing operating cash flow when needed and potentially returning capital when possible.
Per Share Data
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2025 | |||
| Dec 31, 2024 | |||
| Dec 31, 2023 | |||
| Dec 31, 2022 | |||
| Dec 31, 2021 | |||
| Dec 31, 2020 | |||
| Dec 31, 2019 | |||
| Dec 31, 2018 | |||
| Dec 31, 2017 | |||
| Dec 31, 2016 | |||
| Dec 31, 2015 | |||
| Dec 31, 2014 | |||
| Dec 31, 2013 | |||
| Dec 31, 2012 | |||
| Dec 31, 2011 | |||
| Dec 31, 2010 | |||
| Dec 31, 2009 | |||
| Dec 31, 2008 | |||
| Dec 31, 2007 | |||
| Dec 31, 2006 | |||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.
The per share information reveals fluctuating performance over the period examined. Basic and diluted earnings per share (EPS) demonstrate considerable volatility, while dividend per share exhibits a consistent upward trajectory.
- Earnings Per Share (EPS)
- From 2005 to 2007, both basic and diluted EPS increased steadily, reaching 2.71 US$ in 2007. A significant downturn occurred in 2008, with both metrics reporting a loss of -1.89 US$. Subsequent recovery was observed through 2009 and 2010, peaking at 4.58 US$. The years 2011-2014 saw a period of relative stability, with EPS fluctuating between 3.66 US$ and 4.33 US$. Another substantial decline occurred in 2017, resulting in a loss of -0.19 US$. A dramatic increase in EPS is then evident from 2018 onwards, accelerating significantly in 2019 to 8.93 US$ and 8.89 US$ for basic and diluted EPS respectively. While fluctuating between 6.12 US$ and 6.93 US$ in 2020-2021, EPS experienced a substantial surge in 2022 and 2023, reaching 11.76 US$ and 23.00 US$ for basic EPS, and 11.71 US$ and 22.95 US$ for diluted EPS. This upward trend continued into 2025.
- Dividend Per Share
- Dividend per share consistently increased throughout the analyzed period. Starting at 1.54 US$ in 2005, it rose incrementally each year, reaching 6.23 US$ by 2025. The growth rate appeared relatively stable until 2019, after which the annual increases became more pronounced, indicating a growing commitment to returning value to shareholders. The increases from 2019 to 2025 were notably larger than those observed in the earlier years of the period.
The divergence between EPS and dividend per share is noteworthy. While EPS experienced significant fluctuations, including negative values in 2008 and 2017, the dividend per share continued to rise steadily. This suggests a policy of maintaining or increasing dividends even during periods of lower profitability, potentially signaling confidence in future earnings or a commitment to shareholder returns. The substantial increase in EPS from 2019 onwards coincided with accelerated dividend growth, indicating a strengthening financial position.